Your PK Bioanalysis Partner

Move your program forward with pharmacokinetic bioanalysis designed to generate reliable, decision‑ready data. KCAS Bio supports PK studies across discovery, preclinical, and clinical development with methods tailored to your molecule, modality, and regulatory needs.

PK data helps define exposure, guide dose selection, and support a clearer understanding of your molecule’s behavior in the body. A thoughtful PK strategy can reduce uncertainty and help teams advance with confidence throughout development.

PK Bioanalysis Designed Around Your Molecule

KCAS Bio offers custom PK assay development, validation, sample analysis, and reporting. We tailor methods to your molecule, study design, and stage of development, with support for small molecules, biologics, and advanced modalities.

Our PK services leverage a range of analytical technologies, including LC‑MS/MS, ELISA and other immunoassays, and molecular platforms, selecting the best approach for your molecule and study objectives.

Expertise That Drives Better Outcomes

• Flexible, customized assay solutions
• Support from method development through final reporting
• Experience across multiple therapeutic modalities
• Bioanalytical data you can trust for key decisions

Let’s Talk about Your Study
If you’re designing a PK study or need to translate PK data into the next phase of your program, we can help you define the right bioanalytical strategy.

Fill out the form today to get your project started.